Latest Underwriting Agreement News

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.

Red Sky Energy has secured full underwriting for its 2-for-3 non-renounceable rights issue to raise approximately AU$4.2 million, supported by sub-underwriting commitments from related parties. Concurrently, the company has initiated a cost reduction program including a 25% pay cut for senior management and staff reductions.

Tamboran Resources Corporation has secured up to US$198 million through a combination of public and entitlement offers to fund expanded drilling and resource delineation in the Beetaloo Basin, aiming for first gas sales by Q3 2026.

Identitii Limited has secured $200,000 through a placement of approximately 28.57 million shares at $0.007 each to existing shareholders, including Cameron Beavis, to address short-term funding needs while adhering to Takeovers Panel orders related to its Rights Issue.

Red Sky Energy is set to raise up to $5.2 million through a placement and rights issue to fund its participation in a Santos-operated drilling program in South Australia’s Innamincka Dome. The capital raise aims to accelerate near-term production and cash flow from existing and new wells.

Estrella Resources has inked an $8 million underwriting agreement with Million Link (China) Investment Ltd to support the exercise of 445 million listed options, aiming to strengthen its capital position ahead of the options’ December expiry.

Identitii Limited has closed its recent rights issue, raising $379,336 before costs but falling short by $2.5 million after the termination of its underwriting agreement. The company plans to issue new shares and place the remaining shortfall to fund growth initiatives for its BNDRY platform.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.

Identitii Limited faces a setback as Beauvais Capital terminates its underwriting agreement following Takeovers Panel orders, triggering shareholder withdrawal rights and uncertainty over the company’s capital raising plans.